Literature DB >> 10830631

Minimally invasive parasternal approach to tricuspid valve avoids repeat sternotomy.

T Klokocovnik1.   

Abstract

We report the case of a 68-year-old patient with severe tricuspid regurgitation who had previously undergone aortic valve replacement and right coronary artery bypass. We performed tricuspid valvuloplasty via the right parasternal route in order to reduce surgical trauma by avoiding resternotomy, trauma to the venous graft, and bleeding due to dissection of old adhesions. The patient's postoperative course was uneventful, and he was discharged home on the 7th postoperative day.

Entities:  

Mesh:

Year:  2000        PMID: 10830631      PMCID: PMC101021     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  6 in total

1.  Right parasternal incision: a uniform minimally invasive approach for valve operations.

Authors:  R R Lazzara; F E Kidwell
Journal:  Ann Thorac Surg       Date:  1998-01       Impact factor: 4.330

2.  Limited lower sternotomy for minimally invasive mitral valve replacement.

Authors:  R U Nair; D A Sharpe
Journal:  Ann Thorac Surg       Date:  1998-01       Impact factor: 4.330

3.  Minimally invasive approach for aortic valve operations.

Authors:  D M Cosgrove; J F Sabik
Journal:  Ann Thorac Surg       Date:  1996-08       Impact factor: 4.330

4.  Minimally invasive mitral operations.

Authors:  K V Arom; R W Emery
Journal:  Ann Thorac Surg       Date:  1997-04       Impact factor: 4.330

5.  Minimally invasive mitral valve operations.

Authors:  J L Navia; D M Cosgrove
Journal:  Ann Thorac Surg       Date:  1996-11       Impact factor: 4.330

6.  Limited access myocardial revascularization. A preliminary report.

Authors:  D A Cooley
Journal:  Tex Heart Inst J       Date:  1996
  6 in total
  1 in total

1.  Double venous drainage through the superior vena cava in minimally invasive aortic valve replacement: a retrospective study.

Authors:  Tomislav Klokocovnik; Tanja Kersnik Levart; Matjaz Bunc
Journal:  Croat Med J       Date:  2012-02-15       Impact factor: 1.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.